Heather Kelly Marie Bartlett, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 13030 Military Rd S, Suite 106, Tukwila, WA 98168 Phone: 206-246-2886 Fax: 206-246-5457 |
News Archive
Researchers at the Joslin Diabetes Center have shown that an enzyme found in the mitochondria of cells is decreased in the skeletal muscle of those with diabetes, a finding that could lead to the development of drugs to boost the activity of this enzyme in an effort to fight the disease.
A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.
A brand new and patented technology has recently been launched that protects patients from buying and using counterfeit medicines. Pharmaceutical companies can now effectively and very economically protect their products and supply chain with this technology, thus avoiding damages and incalculable liabilities resulting from falsified products.
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced dosing of the first patient in its Phase 2 clinical study of NGX-1998, a liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).
Breastfeeding appears to be associated with decreased risk of overweight and obesity among school children in Japan, according to a study by Michiyo Yamakawa, M.H.Sc., of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama City, Japan, and colleagues.
› Verified 3 days ago